Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan

Objectives: Patients with myeloproliferative neoplasms (MPNs) are at higher risk of developing secondary malignancies. In this study, we focused on patients with MPNs that complicated lymphoid neoplasms. To analyze the real-world status of lymphoid neoplasm treatment in patients with pre-existing MP...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, Michiaki Koike, Koh Izumiyama, Junji Hiraga, Tomofumi Yano, Kensuke Usuki, Eiichi Ohtsuka, Kenji Yokoyama, Tatsuo Oyake, Naoki Takahashi, Tetsuya Nishida, Takafumi Nakao, Yasutaka Fukuda, Takashi Akasaka, Atsuko Mugitani, Miki Ando, Norio Komatsu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
Myeloproliferative neoplasms
polycythemia vera
essential thrombocythemia
myelofibrosis
lymphoid neoplasms
chemotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2340149
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2024.2340149

Similar Items